We perform the first fully consistent analysis of nd scattering at next-to-next-to-leading order in chiral effective field theory including the corresponding three-nucleon force and extending our previous work, where only the two-nucleon interaction has been taken into account. The three-nucleon force appears first at this order in the chiral expansion and depends on two unknown parameters. These two parameters are determined from the triton binding energy and nd doublet scattering length. We find an improved description of various scattering observables in relation to the next-to-leading order results especially at moderate energies (E lab ϭ65 MeV). It is demonstrated that the long-standing A y problem in nd elastic scattering is still not solved by the leading 3NF, although some visible improvement is observed. We discuss possibilities of solving this puzzle. The predicted binding energy for the ␣ particle agrees with the empirical value.
The renormalization of the chiral nuclear interactions is studied. In leading order, the cutoff dependence is related to the singular tensor interaction of the one-pion exchange potential. In S waves and in higher partial waves where the tensor force is repulsive this cutoff dependence can be absorbed by counterterms expected at that order. In the other partial waves additional contact interactions are necessary. The implications of this finding for the effective field theory program in nuclear physics are discussed.
We present new nuclear matter calculations based on low-momentum interactions derived from chiral effective field theory potentials. The current calculations use an improved treatment of the three-nucleon force (3NF) contribution that includes a corrected combinatorial factor beyond Hartree-Fock that was omitted in previous nuclear matter calculations. We find realistic saturation properties using parameters fit only to few-body data, but with larger uncertainty estimates from cutoff dependence and the 3NF parametrization than in previous calculations.
Results for the ΛN and ΣN interactions obtained at next-to-leading order in chiral effective field theory are reported. At the order considered there are contributions from one-and two-pseudoscalar-meson exchange diagrams and from four-baryon contact terms without and with two derivatives. SU(3) flavor symmetry is imposed for constructing the hyperon-nucleon interaction while the explicit SU(3) symmetry breaking by the physical masses of the pseudoscalar mesons (π, K, η) is taken into account. An excellent description of the hyperon-nucleon system can be achieved at next-to-leading order. It is on the same level of quality as the one obtained by the most advanced phenomenological hyperon-nucleon interaction models.
Properties of finite nuclei are evaluated with two-nucleon (NN) and three-nucleon (NNN) interactions derived within chiral effective field theory. The nuclear Hamiltonian is fixed by properties of the A=2 system, except for two low-energy constants (LECs) that parametrize the short range NNN interaction, which we constrain with the A=3 binding energies. We investigate the sensitivity of 4He, 6Li, 10,11B, and 12,13C properties to the variation of the constrained LECs. We identify observables that are sensitive to this variation and find preferred values that give the best overall description. We demonstrate that the NNN interaction terms significantly improve the binding energies and spectra of mid-p-shell nuclei not just with the preferred choice of the LECs but even within a wide range of the constrained LECs. We find that a very high quality description of these nuclei requires further improvements to the chiral Hamiltonian.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.